Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 2Phase 2 2

Status

Recruiting 6Not yet recruiting 4Active not recruiting 4Terminated 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 3Tumor-Agnostic 1

Conditions

Endometrial Neoplasms 3Weight Loss 1Neoplasms 1Menorrhagia 1Leiomyoma 1

Interventions

Specimen Handling 481pembrolizumab 454Magnetic Resonance Spectroscopy 419Carboplatin 321Cyclophosphamide 314Biopsy 272Cisplatin 264Radiotherapy 239Paclitaxel 226Gemcitabine 222Bevacizumab 212Nivolumab 189fludarabine 183venetoclax 172Drug Therapy 165Dexamethasone 157Blood Specimen Collection 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 136Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Radiation 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Megestrol Acetate × 1 year × Clear all
NCT05247268 2026-06-04

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Fudan University

Phase 2 Recruiting
104 enrolled
Gynecologic

Endometrial Neoplasms

NCT05255653 2026-05-15

RAINBO

Leiden University Medical Center

Phase 2/3 Recruiting
1,615 enrolled
Gynecologic

Endometrial Neoplasms

NCT06979596 2026-05-13

OMAHA-015

Merck Sharp & Dohme LLC

Phase 2 Recruiting
250 enrolled
Tumor-Agnostic

Neoplasms

NCT07319429 2026-03-13

FEMUS

Fudan University

Phase 2/3 Recruiting
260 enrolled
Gynecologic

Endometrial Neoplasms

NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting
120 enrolled

Leiomyoma, Menorrhagia

NCT06998758 2025-12-12

MATRIX

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Recruiting
60 enrolled

Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡